Literature DB >> 22032427

Pleural effusions.

Richard W Light1.   

Abstract

There are many diseases that cause pleural effusions. When a patient with a pleural effusion is first evaluated, one should determine if the patient has a transudate or an exudate. A diagnostic approach to the patient with an undiagnosed pleural effusion is outlined. The most common pleural effusions including those caused by congestive heart failure, cirrhosis, pneumonia, malignancy, tuberculosis, lupus erythematosus, rheumatoid disease, and chylothorax are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 22032427     DOI： 10.1016/j.mcna.2011.08.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  53 in total

1.  Mortality among patients with pleural effusion undergoing thoracentesis.

Authors:  Erin M DeBiasi; Margaret A Pisani; Terrence E Murphy; Katy Araujo; Anna Kookoolis; A Christine Argento; Jonathan Puchalski
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

2.  Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Authors:  Piotr Korczyński; Katarzyna Górska; Damian Konopka; Dżamila Al-Haj; Krzysztof J Filipiak; Rafał Krenke
Journal:  Cardiol J       Date:  2018-11-08       Impact factor: 2.737

Review 3.  Evaluation of the patient with pleural effusion.

Authors:  Stéphane Beaudoin; Anne V Gonzalez
Journal:  CMAJ       Date:  2018-03-12       Impact factor: 8.262

4.  Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion.

Authors:  Emily Jeffery; Yc Gary Lee; Joanne McVeigh; Leon Straker; Troy Wooding; Robert U Newton; Carolyn Peddle-McIntyre
Journal:  Support Care Cancer       Date:  2017-04-28       Impact factor: 3.603

5.  Predictive models of malignant transudative pleural effusions.

Authors:  Lucía Ferreiro; Francisco Gude; María E Toubes; Adriana Lama; Juan Suárez-Antelo; Esther San-José; Francisco Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; Carlos Rábade; Nuria Rodríguez-Núñez; Carla Díaz-Louzao; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 6.  Medical thoracoscopy and its evolving role in the diagnosis and treatment of pleural disease.

Authors:  Vivek Murthy; Jamie L Bessich
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

7.  Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA.

Authors:  Rosa Filiberti; Stefano Parodi; Roberta Libener; Giovanni Paolo Ivaldi; Pier Aldo Canessa; Donatella Ugolini; Barbara Bobbio; Paola Marroni
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

Review 8.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

9.  Good response of malignant pleural effusion from carcinoma of unknown primary site to the anti-tuberculosis therapy: a case report.

Authors:  Qihua Gu; Chengping Hu; Jingjing Qu
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

10.  Clinical significance of Glasgow Prognostic Score in patients with tuberculous pleurisy.

Authors:  Hye Seon Kang; Hwa Young Lee; Jung Im Jung; Ju Sang Kim; Yong Hyun Kim; Seung Joon Kim; Seok Chan Kim; Soon Seog Kwon; Young Kyoon Kim; Ji Young Kang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.